Home/Filings/4/0000899243-20-012179

4//SEC Filing

NBVM GP, LLC 4

Accession 0000899243-20-012179

CIK 0001327273other

View on SEC.gov Company Profile

Filed

May 5, 8:00 PM ET

Accepted

May 6, 7:38 PM ET

Size

101.3 KB

Accession

0000899243-20-012179

Insider Transaction Report

Form 4

Period: 2020-05-05

Lyra Therapeutics, Inc.LYRA

North Bridge Venture Management VI, L.P.

10% Owner

Transactions

Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,647,727→ 0 total(indirect: See footnote)
→ Common Stock (47,783 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−3,051,758→ 0 total(indirect: See footnote)
→ Common Stock (88,500 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−2,420,729→ 0 total(indirect: See footnote)
→ Common Stock (70,200 underlying)
Purchase
Common Stock
2020-05-05$16.00/sh+57,561$920,976→ 381,618 total(indirect: See Footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+75,000$1,200,000→ 553,123 total(indirect: See Footnote)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−3,270,702→ 0 total(indirect: See footnote)
→ Common Stock (94,849 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−1,835,743→ 0 total(indirect: See footnote)
→ Common Stock (53,236 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,531,507→ 0 total(indirect: See footnote)
→ Common Stock (44,413 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−10,322→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)
Conversion
Common Stock
2020-05-05+471,929→ 471,929 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−5,568$89,088→ 324,057 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+13,449$116,065→ 485,378 total(indirect: See footnote)
Conversion
Common Stock
2020-05-05+651,453→ 651,453 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+21,060$181,748→ 672,513 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−11,360$181,760→ 661,153 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−7,255$116,080→ 478,123 total(indirect: See footnote)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,948,948→ 0 total(indirect: See footnote)
→ Common Stock (56,519 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−4,587,608→ 0 total(indirect: See footnote)
→ Common Stock (133,039 underlying)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+10,322$89,079→ 329,625 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−567,420→ 0 total(indirect: See footnote)
→ Common Stock (16,455 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,105,754→ 0 total(indirect: See footnote)
→ Common Stock (32,066 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−541,973→ 0 total(indirect: See footnote)
→ Common Stock (15,717 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−1,603,102→ 0 total(indirect: See footnote)
→ Common Stock (46,489 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−2,088,772→ 0 total(indirect: See footnote)
→ Common Stock (60,573 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,929,790→ 0 total(indirect: See footnote)
→ Common Stock (84,963 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,995,489→ 0 total(indirect: See footnote)
→ Common Stock (57,868 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,186,496→ 0 total(indirect: See footnote)
→ Common Stock (34,408 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−21,060→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)
Conversion
Common Stock
2020-05-05+319,303→ 319,303 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+117,439$1,879,024→ 778,592 total(indirect: See Footnote)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,248,569→ 0 total(indirect: See footnote)
→ Common Stock (65,208 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−3,745,346→ 0 total(indirect: See footnote)
→ Common Stock (108,614 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−2,391,895→ 0 total(indirect: See footnote)
→ Common Stock (69,364 underlying)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,157,670→ 0 total(indirect: See footnote)
→ Common Stock (33,572 underlying)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,725,090→ 0 total(indirect: See footnote)
→ Common Stock (50,027 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,495,786→ 0 total(indirect: See footnote)
→ Common Stock (43,377 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,545,953→ 0 total(indirect: See footnote)
→ Common Stock (44,832 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−3,124,633→ 0 total(indirect: See footnote)
→ Common Stock (90,613 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−13,449→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)

NBVM GP, LLC

10% Owner

Transactions

Purchase
Common Stock
2020-05-05$16.00/sh+117,439$1,879,024→ 778,592 total(indirect: See Footnote)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−3,051,758→ 0 total(indirect: See footnote)
→ Common Stock (88,500 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,531,507→ 0 total(indirect: See footnote)
→ Common Stock (44,413 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−2,420,729→ 0 total(indirect: See footnote)
→ Common Stock (70,200 underlying)
Sale
Common Stock
2020-05-05$16.00/sh−11,360$181,760→ 661,153 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+13,449$116,065→ 485,378 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+57,561$920,976→ 381,618 total(indirect: See Footnote)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,647,727→ 0 total(indirect: See footnote)
→ Common Stock (47,783 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−3,745,346→ 0 total(indirect: See footnote)
→ Common Stock (108,614 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−2,391,895→ 0 total(indirect: See footnote)
→ Common Stock (69,364 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,995,489→ 0 total(indirect: See footnote)
→ Common Stock (57,868 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,186,496→ 0 total(indirect: See footnote)
→ Common Stock (34,408 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−10,322→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+21,060$181,748→ 672,513 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+10,322$89,079→ 329,625 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−5,568$89,088→ 324,057 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−567,420→ 0 total(indirect: See footnote)
→ Common Stock (16,455 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−541,973→ 0 total(indirect: See footnote)
→ Common Stock (15,717 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,495,786→ 0 total(indirect: See footnote)
→ Common Stock (43,377 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,948,948→ 0 total(indirect: See footnote)
→ Common Stock (56,519 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−1,603,102→ 0 total(indirect: See footnote)
→ Common Stock (46,489 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−2,088,772→ 0 total(indirect: See footnote)
→ Common Stock (60,573 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−4,587,608→ 0 total(indirect: See footnote)
→ Common Stock (133,039 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,248,569→ 0 total(indirect: See footnote)
→ Common Stock (65,208 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−3,124,633→ 0 total(indirect: See footnote)
→ Common Stock (90,613 underlying)
Conversion
Common Stock
2020-05-05+651,453→ 651,453 total(indirect: See footnote)
Conversion
Common Stock
2020-05-05+319,303→ 319,303 total(indirect: See footnote)
Conversion
Common Stock
2020-05-05+471,929→ 471,929 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+75,000$1,200,000→ 553,123 total(indirect: See Footnote)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,545,953→ 0 total(indirect: See footnote)
→ Common Stock (44,832 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−21,060→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)
Sale
Common Stock
2020-05-05$16.00/sh−7,255$116,080→ 478,123 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,157,670→ 0 total(indirect: See footnote)
→ Common Stock (33,572 underlying)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,725,090→ 0 total(indirect: See footnote)
→ Common Stock (50,027 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,105,754→ 0 total(indirect: See footnote)
→ Common Stock (32,066 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−3,270,702→ 0 total(indirect: See footnote)
→ Common Stock (94,849 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,929,790→ 0 total(indirect: See footnote)
→ Common Stock (84,963 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−1,835,743→ 0 total(indirect: See footnote)
→ Common Stock (53,236 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−13,449→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)

DAMORE RICHARD A

10% Owner

Transactions

Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−2,391,895→ 0 total(indirect: See footnote)
→ Common Stock (69,364 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,545,953→ 0 total(indirect: See footnote)
→ Common Stock (44,832 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−13,449→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)
Conversion
Common Stock
2020-05-05+319,303→ 319,303 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−567,420→ 0 total(indirect: See footnote)
→ Common Stock (16,455 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,105,754→ 0 total(indirect: See footnote)
→ Common Stock (32,066 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−4,587,608→ 0 total(indirect: See footnote)
→ Common Stock (133,039 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,929,790→ 0 total(indirect: See footnote)
→ Common Stock (84,963 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−1,835,743→ 0 total(indirect: See footnote)
→ Common Stock (53,236 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−3,124,633→ 0 total(indirect: See footnote)
→ Common Stock (90,613 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,995,489→ 0 total(indirect: See footnote)
→ Common Stock (57,868 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−2,420,729→ 0 total(indirect: See footnote)
→ Common Stock (70,200 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−21,060→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)
Conversion
Common Stock
2020-05-05+651,453→ 651,453 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,725,090→ 0 total(indirect: See footnote)
→ Common Stock (50,027 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−541,973→ 0 total(indirect: See footnote)
→ Common Stock (15,717 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,647,727→ 0 total(indirect: See footnote)
→ Common Stock (47,783 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−3,051,758→ 0 total(indirect: See footnote)
→ Common Stock (88,500 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,495,786→ 0 total(indirect: See footnote)
→ Common Stock (43,377 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,948,948→ 0 total(indirect: See footnote)
→ Common Stock (56,519 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−1,603,102→ 0 total(indirect: See footnote)
→ Common Stock (46,489 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−2,088,772→ 0 total(indirect: See footnote)
→ Common Stock (60,573 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,248,569→ 0 total(indirect: See footnote)
→ Common Stock (65,208 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,531,507→ 0 total(indirect: See footnote)
→ Common Stock (44,413 underlying)
Conversion
Common Stock
2020-05-05+471,929→ 471,929 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+21,060$181,748→ 672,513 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−11,360$181,760→ 661,153 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+10,322$89,079→ 329,625 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−5,568$89,088→ 324,057 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+13,449$116,065→ 485,378 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−7,255$116,080→ 478,123 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+117,439$1,879,024→ 778,592 total(indirect: See Footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+57,561$920,976→ 381,618 total(indirect: See Footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+75,000$1,200,000→ 553,123 total(indirect: See Footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,157,670→ 0 total(indirect: See footnote)
→ Common Stock (33,572 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−3,270,702→ 0 total(indirect: See footnote)
→ Common Stock (94,849 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−3,745,346→ 0 total(indirect: See footnote)
→ Common Stock (108,614 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,186,496→ 0 total(indirect: See footnote)
→ Common Stock (34,408 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−10,322→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)

NORTH BRIDGE VENTURE PARTNERS V-B LP

10% Owner

Transactions

Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,105,754→ 0 total(indirect: See footnote)
→ Common Stock (32,066 underlying)
Purchase
Common Stock
2020-05-05$16.00/sh+117,439$1,879,024→ 778,592 total(indirect: See Footnote)
Exercise of In-Money
Common Warrants
2020-05-05−13,449→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)
Conversion
Common Stock
2020-05-05+651,453→ 651,453 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−11,360$181,760→ 661,153 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−5,568$89,088→ 324,057 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+13,449$116,065→ 485,378 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+57,561$920,976→ 381,618 total(indirect: See Footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+75,000$1,200,000→ 553,123 total(indirect: See Footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−567,420→ 0 total(indirect: See footnote)
→ Common Stock (16,455 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,531,507→ 0 total(indirect: See footnote)
→ Common Stock (44,413 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,995,489→ 0 total(indirect: See footnote)
→ Common Stock (57,868 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,545,953→ 0 total(indirect: See footnote)
→ Common Stock (44,832 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−10,322→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−541,973→ 0 total(indirect: See footnote)
→ Common Stock (15,717 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,647,727→ 0 total(indirect: See footnote)
→ Common Stock (47,783 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−3,051,758→ 0 total(indirect: See footnote)
→ Common Stock (88,500 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,948,948→ 0 total(indirect: See footnote)
→ Common Stock (56,519 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−2,088,772→ 0 total(indirect: See footnote)
→ Common Stock (60,573 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−3,745,346→ 0 total(indirect: See footnote)
→ Common Stock (108,614 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−3,124,633→ 0 total(indirect: See footnote)
→ Common Stock (90,613 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,186,496→ 0 total(indirect: See footnote)
→ Common Stock (34,408 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−21,060→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)
Conversion
Common Stock
2020-05-05+471,929→ 471,929 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+21,060$181,748→ 672,513 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+10,322$89,079→ 329,625 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−7,255$116,080→ 478,123 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,157,670→ 0 total(indirect: See footnote)
→ Common Stock (33,572 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,495,786→ 0 total(indirect: See footnote)
→ Common Stock (43,377 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−4,587,608→ 0 total(indirect: See footnote)
→ Common Stock (133,039 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,929,790→ 0 total(indirect: See footnote)
→ Common Stock (84,963 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−2,391,895→ 0 total(indirect: See footnote)
→ Common Stock (69,364 underlying)
Conversion
Common Stock
2020-05-05+319,303→ 319,303 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,725,090→ 0 total(indirect: See footnote)
→ Common Stock (50,027 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−3,270,702→ 0 total(indirect: See footnote)
→ Common Stock (94,849 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−1,603,102→ 0 total(indirect: See footnote)
→ Common Stock (46,489 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,248,569→ 0 total(indirect: See footnote)
→ Common Stock (65,208 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−1,835,743→ 0 total(indirect: See footnote)
→ Common Stock (53,236 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−2,420,729→ 0 total(indirect: See footnote)
→ Common Stock (70,200 underlying)

NORTH BRIDGE VENTURE PARTNERS V A LP

10% Owner

Transactions

Conversion
Common Stock
2020-05-05+651,453→ 651,453 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+21,060$181,748→ 672,513 total(indirect: See footnote)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,647,727→ 0 total(indirect: See footnote)
→ Common Stock (47,783 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,495,786→ 0 total(indirect: See footnote)
→ Common Stock (43,377 underlying)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+10,322$89,079→ 329,625 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−5,568$89,088→ 324,057 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−567,420→ 0 total(indirect: See footnote)
→ Common Stock (16,455 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,105,754→ 0 total(indirect: See footnote)
→ Common Stock (32,066 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−1,603,102→ 0 total(indirect: See footnote)
→ Common Stock (46,489 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−4,587,608→ 0 total(indirect: See footnote)
→ Common Stock (133,039 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,929,790→ 0 total(indirect: See footnote)
→ Common Stock (84,963 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−1,835,743→ 0 total(indirect: See footnote)
→ Common Stock (53,236 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−2,391,895→ 0 total(indirect: See footnote)
→ Common Stock (69,364 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,995,489→ 0 total(indirect: See footnote)
→ Common Stock (57,868 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,545,953→ 0 total(indirect: See footnote)
→ Common Stock (44,832 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−21,060→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)
Conversion
Common Stock
2020-05-05+471,929→ 471,929 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−11,360$181,760→ 661,153 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+13,449$116,065→ 485,378 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+57,561$920,976→ 381,618 total(indirect: See Footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,157,670→ 0 total(indirect: See footnote)
→ Common Stock (33,572 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−541,973→ 0 total(indirect: See footnote)
→ Common Stock (15,717 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−3,051,758→ 0 total(indirect: See footnote)
→ Common Stock (88,500 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−3,270,702→ 0 total(indirect: See footnote)
→ Common Stock (94,849 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−2,088,772→ 0 total(indirect: See footnote)
→ Common Stock (60,573 underlying)
Conversion
Common Stock
2020-05-05+319,303→ 319,303 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−7,255$116,080→ 478,123 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+117,439$1,879,024→ 778,592 total(indirect: See Footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+75,000$1,200,000→ 553,123 total(indirect: See Footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,725,090→ 0 total(indirect: See footnote)
→ Common Stock (50,027 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,948,948→ 0 total(indirect: See footnote)
→ Common Stock (56,519 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,248,569→ 0 total(indirect: See footnote)
→ Common Stock (65,208 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−3,745,346→ 0 total(indirect: See footnote)
→ Common Stock (108,614 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−3,124,633→ 0 total(indirect: See footnote)
→ Common Stock (90,613 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,531,507→ 0 total(indirect: See footnote)
→ Common Stock (44,413 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−2,420,729→ 0 total(indirect: See footnote)
→ Common Stock (70,200 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−10,322→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,186,496→ 0 total(indirect: See footnote)
→ Common Stock (34,408 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−13,449→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)

North Bridge Venture Partners VI L P

10% Owner

Transactions

Sale
Common Stock
2020-05-05$16.00/sh−5,568$89,088→ 324,057 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−7,255$116,080→ 478,123 total(indirect: See footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,157,670→ 0 total(indirect: See footnote)
→ Common Stock (33,572 underlying)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,725,090→ 0 total(indirect: See footnote)
→ Common Stock (50,027 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−541,973→ 0 total(indirect: See footnote)
→ Common Stock (15,717 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,647,727→ 0 total(indirect: See footnote)
→ Common Stock (47,783 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−2,088,772→ 0 total(indirect: See footnote)
→ Common Stock (60,573 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,248,569→ 0 total(indirect: See footnote)
→ Common Stock (65,208 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,531,507→ 0 total(indirect: See footnote)
→ Common Stock (44,413 underlying)
Conversion
Common Stock
2020-05-05+651,453→ 651,453 total(indirect: See footnote)
Conversion
Common Stock
2020-05-05+319,303→ 319,303 total(indirect: See footnote)
Conversion
Common Stock
2020-05-05+471,929→ 471,929 total(indirect: See footnote)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,995,489→ 0 total(indirect: See footnote)
→ Common Stock (57,868 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,186,496→ 0 total(indirect: See footnote)
→ Common Stock (34,408 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−13,449→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−567,420→ 0 total(indirect: See footnote)
→ Common Stock (16,455 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−3,051,758→ 0 total(indirect: See footnote)
→ Common Stock (88,500 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,495,786→ 0 total(indirect: See footnote)
→ Common Stock (43,377 underlying)
Sale
Common Stock
2020-05-05$16.00/sh−11,360$181,760→ 661,153 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+10,322$89,079→ 329,625 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+13,449$116,065→ 485,378 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+117,439$1,879,024→ 778,592 total(indirect: See Footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+57,561$920,976→ 381,618 total(indirect: See Footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+75,000$1,200,000→ 553,123 total(indirect: See Footnote)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−1,603,102→ 0 total(indirect: See footnote)
→ Common Stock (46,489 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−4,587,608→ 0 total(indirect: See footnote)
→ Common Stock (133,039 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,929,790→ 0 total(indirect: See footnote)
→ Common Stock (84,963 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−2,391,895→ 0 total(indirect: See footnote)
→ Common Stock (69,364 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−3,124,633→ 0 total(indirect: See footnote)
→ Common Stock (90,613 underlying)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+21,060$181,748→ 672,513 total(indirect: See footnote)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,105,754→ 0 total(indirect: See footnote)
→ Common Stock (32,066 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,948,948→ 0 total(indirect: See footnote)
→ Common Stock (56,519 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−3,270,702→ 0 total(indirect: See footnote)
→ Common Stock (94,849 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−3,745,346→ 0 total(indirect: See footnote)
→ Common Stock (108,614 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−1,835,743→ 0 total(indirect: See footnote)
→ Common Stock (53,236 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−2,420,729→ 0 total(indirect: See footnote)
→ Common Stock (70,200 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,545,953→ 0 total(indirect: See footnote)
→ Common Stock (44,832 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−21,060→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−10,322→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)

North Bridge Venture Management V, L.P.

10% Owner

Transactions

Conversion
Common Stock
2020-05-05+319,303→ 319,303 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+21,060$181,748→ 672,513 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−5,568$89,088→ 324,057 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−7,255$116,080→ 478,123 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+117,439$1,879,024→ 778,592 total(indirect: See Footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−567,420→ 0 total(indirect: See footnote)
→ Common Stock (16,455 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−3,051,758→ 0 total(indirect: See footnote)
→ Common Stock (88,500 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,495,786→ 0 total(indirect: See footnote)
→ Common Stock (43,377 underlying)
Conversion
Series A-1/C Convertible Preferred Stock
2020-05-05−1,948,948→ 0 total(indirect: See footnote)
→ Common Stock (56,519 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−3,270,702→ 0 total(indirect: See footnote)
→ Common Stock (94,849 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,248,569→ 0 total(indirect: See footnote)
→ Common Stock (65,208 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−2,929,790→ 0 total(indirect: See footnote)
→ Common Stock (84,963 underlying)
Conversion
Common Stock
2020-05-05+651,453→ 651,453 total(indirect: See footnote)
Sale
Common Stock
2020-05-05$16.00/sh−11,360$181,760→ 661,153 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+10,322$89,079→ 329,625 total(indirect: See footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+57,561$920,976→ 381,618 total(indirect: See Footnote)
Purchase
Common Stock
2020-05-05$16.00/sh+75,000$1,200,000→ 553,123 total(indirect: See Footnote)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,157,670→ 0 total(indirect: See footnote)
→ Common Stock (33,572 underlying)
Conversion
Series A-1/A Convertible Preferred Stock
2020-05-05−1,725,090→ 0 total(indirect: See footnote)
→ Common Stock (50,027 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,105,754→ 0 total(indirect: See footnote)
→ Common Stock (32,066 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−541,973→ 0 total(indirect: See footnote)
→ Common Stock (15,717 underlying)
Conversion
Series A-1/B Convertible Preferred Stock
2020-05-05−1,647,727→ 0 total(indirect: See footnote)
→ Common Stock (47,783 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−1,603,102→ 0 total(indirect: See footnote)
→ Common Stock (46,489 underlying)
Conversion
Series A-2 Convertible Preferred Stock
2020-05-05−2,088,772→ 0 total(indirect: See footnote)
→ Common Stock (60,573 underlying)
Conversion
Series A-3 Convertible Preferred Stock
2020-05-05−4,587,608→ 0 total(indirect: See footnote)
→ Common Stock (133,039 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−1,835,743→ 0 total(indirect: See footnote)
→ Common Stock (53,236 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−3,124,633→ 0 total(indirect: See footnote)
→ Common Stock (90,613 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−2,420,729→ 0 total(indirect: See footnote)
→ Common Stock (70,200 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−13,449→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (13,449 underlying)
Conversion
Common Stock
2020-05-05+471,929→ 471,929 total(indirect: See footnote)
Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+13,449$116,065→ 485,378 total(indirect: See footnote)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−3,745,346→ 0 total(indirect: See footnote)
→ Common Stock (108,614 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,531,507→ 0 total(indirect: See footnote)
→ Common Stock (44,413 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−21,060→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (21,060 underlying)
Conversion
Series A-4 Convertible Preferred Stock
2020-05-05−2,391,895→ 0 total(indirect: See footnote)
→ Common Stock (69,364 underlying)
Conversion
Series B Convertible Preferred Stock
2020-05-05−1,995,489→ 0 total(indirect: See footnote)
→ Common Stock (57,868 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,186,496→ 0 total(indirect: See footnote)
→ Common Stock (34,408 underlying)
Conversion
Series C Convertible Preferred Stock
2020-05-05−1,545,953→ 0 total(indirect: See footnote)
→ Common Stock (44,832 underlying)
Exercise of In-Money
Common Warrants
2020-05-05−10,322→ 0 total(indirect: See footnote)
Exercise: $8.63From: 2020-01-17Exp: 2030-01-10→ Common Stock (10,322 underlying)

Footnotes (7)

[F1]Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date.
[F2]The reportable securities are owned directly by North Bridge Venture Partners V-A, L.P. ("NBVP V-A"). North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
[F3]The reportable securities are owned directly by North Bridge Venture Partners V-B, L.P. ("NBVP V-B"). NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
[F4]The reportable securities are owned directly by North Bridge Venture Partners VI, L.P. ("NBVP VI"). North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
[F5]On May 5, 2020, NBVP V-A exercised a warrant to purchase 21,060 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 11,360 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP V-A. The Issuer also paid $12.20 to NBVP V-A in lieu of a fractional share.
[F6]On May 5, 2020, NBVP V-B exercised a warrant to purchsae 10,322 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 5,568 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP V-B. The Issuer also paid $9.14 to NBVP V-B in lieu of a fractional share.
[F7]On May 5, 2020, NBVP VI exercised a warrant to purchase 13,449 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 7,255 of the warrant shares to pay the exercise price and issued the remaining warrant shares to NBVP VI. The Issuer also paid $15.13 to NBVP VI in lieu of a fractional share.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001401650

Filing Metadata

Form type: 4
Filed: May 5, 8:00 PM ET
Accepted: May 6, 7:38 PM ET
Size: 101.3 KB

View on SEC.gov